The European Commission has approved dimethyl fumarate (Tecfidera, Biogen Idec) as a first-line oral treatment in relapsing-remitting multiple sclerosis (MS), the company reported today. Dimethyl ...
Verywell Health on MSN
A guide to multiple sclerosis medications
Medically reviewed by Lindsay Cook, PharmD Key Takeaways MS medications can help slow the disease and manage symptoms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results